Since epidemiological studies suggested a protective effect of reduced expression of CD33 in human AD and previous studies in mice provided evidence for a role of microglia in that mechanisms, we here wanted to address whether a combination of CD33 reduction and passive immunotherapy exerts an additive effect on lowering Aβ deposition. The gene discussed is CD33; the disease is Alzheimer disease.